Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34


Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.

Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, Gammon A, Butler K, Buys SS, Stroup AM, Campo RA, Flores KG, Mandelblatt JS, Schwartz MD.

J Clin Oncol. 2016 Aug 20;34(24):2914-24. doi: 10.1200/JCO.2015.65.9557.


Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour.

Silarova B, Lucas J, Butterworth AS, Di Angelantonio E, Girling C, Lawrence K, Mackintosh S, Moore C, Payne RA, Sharp SJ, Shefer G, Tolkien Z, Usher-Smith J, Walker M, Danesh J, Griffin S.

BMC Public Health. 2015 Sep 7;15:868. doi: 10.1186/s12889-015-2192-5.


Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.

Ali N, Lifford KJ, Carter B, McRonald F, Yadegarfar G, Baldwin DR, Weller D, Hansell DM, Duffy SW, Field JK, Brain K.

BMJ Open. 2015 Jul 14;5(7):e008254. doi: 10.1136/bmjopen-2015-008254.


The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trial.

Henneman L, Oosterwijk JC, van Asperen CJ, Menko FH, Ockhuysen-Vermey CF, Kostense PJ, Claassen L, Timmermans DR.

BMC Med Inform Decis Mak. 2013 Apr 29;13:55. doi: 10.1186/1472-6947-13-55.


Development and validation of a brief screening instrument for psychosocial risk associated with genetic testing: a pan-Canadian cohort study.

Esplen MJ, Cappelli M, Wong J, Bottorff JL, Hunter J, Carroll J, Dorval M, Wilson B, Allanson J, Semotiuk K, Aronson M, Bordeleau L, Charlemagne N, Meschino W.

BMJ Open. 2013 Mar 13;3(3). pii: e002227. doi: 10.1136/bmjopen-2012-002227.


Effect of communicating genetic and phenotypic risk for type 2 diabetes in combination with lifestyle advice on objectively measured physical activity: protocol of a randomised controlled trial.

Godino JG, van Sluijs EM, Marteau TM, Sutton S, Sharp SJ, Griffin SJ.

BMC Public Health. 2012 Jun 18;12:444. doi: 10.1186/1471-2458-12-444.


Using a family history intervention to improve cancer risk perception in a black community.

Murthy VS, Garza MA, Almario DA, Vogel KJ, Grubs RE, Gettig EA, Wilson JW, Thomas SB.

J Genet Couns. 2011 Dec;20(6):639-49. doi: 10.1007/s10897-011-9389-2.


Factors influencing cancer risk perception in high risk populations: a systematic review.

Tilburt JC, James KM, Sinicrope PS, Eton DT, Costello BA, Carey J, Lane MA, Ehlers SL, Erwin PJ, Nowakowski KE, Murad MH.

Hered Cancer Clin Pract. 2011 May 19;9:2. doi: 10.1186/1897-4287-9-2.


Objective and subjective breast cancer risk: relationships with natural killer cell activity and psychological distress in healthy women.

Park NJ, Kang DH, Weaver MT.

Cancer Nurs. 2010 Nov-Dec;33(6):411-20. doi: 10.1097/NCC.0b013e3181dc37a1.


"I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.

Linnenbringer E, Roberts JS, Hiraki S, Cupples LA, Green RC.

Genet Med. 2010 Apr;12(4):219-27. doi: 10.1097/GIM.0b013e3181cef9e1.


Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers.

Caruso A, Vigna C, Marozzo B, Sega FM, Sperduti I, Cognetti F, Savarese A.

J Exp Clin Cancer Res. 2009 Dec 21;28:157. doi: 10.1186/1756-9966-28-157.


Risk perceptions among participants undergoing lung cancer screening: baseline results from the National Lung Screening Trial.

Park ER, Ostroff JS, Rakowski W, Gareen IF, Diefenbach MA, Feibelmann S, Rigotti NA.

Ann Behav Med. 2009 Jun;37(3):268-79. doi: 10.1007/s12160-009-9112-9.


Anchoring-and-adjustment bias in communication of disease risk.

Senay I, Kaphingst KA.

Med Decis Making. 2009 Mar-Apr;29(2):193-201. doi: 10.1177/0272989X08327395. Review.


Measuring, and identifying predictors of women's perceptions of three types of breast cancer risk: population risk, absolute risk and comparative risk.

Apicella C, Peacock SJ, Andrews L, Tucker K, Daly MB, Hopper JL.

Br J Cancer. 2009 Feb 24;100(4):583-9. doi: 10.1038/sj.bjc.6604910.


Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling.

Ockhuysen-Vermey CF, Henneman L, van Asperen CJ, Oosterwijk JC, Menko FH, Timmermans DR.

BMC Cancer. 2008 Oct 3;8:283. doi: 10.1186/1471-2407-8-283.


The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care.

Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, Kinmonth AL.

Br J Cancer. 2007 Aug 20;97(4):486-93.


Assessing oral literacy demand in genetic counseling dialogue: preliminary test of a conceptual framework.

Roter DL, Erby LH, Larson S, Ellington L.

Soc Sci Med. 2007 Oct;65(7):1442-57.


Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.

Foster C, Watson M, Eeles R, Eccles D, Ashley S, Davidson R, Mackay J, Morrison PJ, Hopwood P, Evans DG; Psychosocial Study Collaborators..

Br J Cancer. 2007 Mar 12;96(5):718-24.


Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials.

Torrance N, Mollison J, Wordsworth S, Gray J, Miedzybrodzka Z, Haites N, Grant A, Campbell M, Watson MS, Clarke A, Wilson B.

Br J Cancer. 2006 Aug 21;95(4):435-44.

Items per page

Supplemental Content

Support Center